Coherus Reveals Sales Have Started Piling In On Pegfilgrastim

 
• By Aidan Fry
  
MoneyStack
Coherus has needed less than three months to generate significant US sales from its Udenyca pegfilgrastim biosimilar • Source: Shutterstock

More from Biosimilars

More from Products